Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, October 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 5,713 followers.

Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF... http://t.co/dYQgHXqA1N

Cancer/sNews: Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as... http://t.co/zn15ozutrg

Chem: Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel… http://t.co/4c1evTTroX

CD15/FUT4 overexpression decreases benefit to drugs targeting EGFR or VEGF in metastatic #colorectal #cancer http://t.co/e77qQnKkWZ

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.